首页 | 本学科首页   官方微博 | 高级检索  
检索        

低分子肝素钙治疗不稳定型心绞痛81例临床观察
引用本文:张远政,赵崇瑜.低分子肝素钙治疗不稳定型心绞痛81例临床观察[J].中国医药,2009,4(2):91-92.
作者姓名:张远政  赵崇瑜
作者单位:南海西部石油公司职工医院心内科,广东省湛江市,524057
摘    要:目的观察低分子肝素钙治疗不稳定型心绞痛的临床疗效。方法162例不稳定型心绞痛患者按人院顺序随机分为对照组和治疗组各81例。2组患者均接受常规治疗,在此基础上治疗组患者加用低分子肝素钙0.1ml/10kg(851U/kg),腹壁皮下注射,1次/12h,连用14d。结果治疗组总有效76例(93.8%),高于对照组的60例(74.0%),差异有统计学意义(P〈0.05)。治疗组心绞痛发作次数、持续时间、发作间隔时间、硝酸甘油用量心电图结果及血液流变学等改善情况均优于对照组,差异有统计学意义(P〈0.05或P〈0.01)。结论低分子肝素钙治疗不稳定型心绞痛具有较好的疗效,改善了不稳定型心绞痛患者的近期预后,且治疗过程中未见明显不良反应。

关 键 词:不稳定型心绞痛  低分子肝素钙

Clinical observation of low-molecular weight heparin in treatment of unstable angina
ZHANG Yuan-zheng,ZHAO Chong-yu.Clinical observation of low-molecular weight heparin in treatment of unstable angina[J].China Medicine,2009,4(2):91-92.
Authors:ZHANG Yuan-zheng  ZHAO Chong-yu
Institution:(Department of Cardiology, The Worker's Hospital of Offshore Nan Hal West Corporation, Zhanjiang 524057, China)
Abstract:Objective To investigate the clinical therapeutic effective of low-molecular weight heparin (LMWH) in patients with unstable angina(UA). Methods One hundred and sixty-two UA patients were randomly divided into control and treatment group. Patients in treatment group had a therapy of LMWH (0.1 ml/10 kg,twice a day). Results The total effective rate in treatment group was 93.8% and 74.0% in control group (P<0.05).Meanwhile the LMWH decreased the frequency and duration of angina pectoris, nitroglycerin consumption, and improved hameorheology(P<0.05). Conclusion LMWH is a valuable therapy for UAP patients.
Keywords:Unstable angina  Low-molecular weight heparin
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号